Read + Share
Stroyakovskiy DL, Fadeeva NV, Matrosova MP, Shelepen KG, et al. Randomized double-blind clinical trial comparing safety and efficacy of the
biosimilar BCD-021 with reference bevacizumab. BMC Cancer 2022;22:129.
PMID: 35105329
|
 |
|
Stroyakovskiy DL, Fadeeva NV, Matrosova MP, Shelepen KG, et al. Randomized double-blind clinical trial comparing safety and efficacy of the
biosimilar BCD-021 with reference bevacizumab. BMC Cancer 2022;22:129.
PMID: 35105329
|
|
|
|